Important note: Information in this article was accurate in 2007. The state of the art may have changed since the publication date.
 |
New Vision (Kampala) - October 26, 2007
Raymond Baguma
The grant is expected to benefit 255,000 people in the next four years, including 110,000 mothers and 35,000 patients with sexually transmitted diseases.
A joint statement issued by World Bank and KfW on Wednesday said the funds will run a programme introduced last year where patients use vouchers to access treatment at participating health facilities.
"The medical service providers are reimbursed after service provision. In return, the project will provide them with a secure income stream if they are able to provide quality service and attract patients," read the statement.
"Use of local doctors and midwives for the project will increase local capacity for providing affordable health services to the poor. It will provide safe child delivery packages including four ante-natal visits, delivery attended by a medical professional and one post-natal visit," the statement added.
The grant will be managed under the World Bank's Global Partnership on Output-Based Aid, a partnership of various donor organisations.
Wolfgang Kroh, a KfW board member, said: "German financial cooperation aims at strengthening systems of social protection for the poor. Let us jointly support this new conceptual approach to pro-poor service delivery as well as health financing under private sector participation."
The 2007 progress report on Millennium Development Goals shows that Uganda's infant mortality rate stands at 76 deaths per 1,000 live births, while maternal mortality is 505 deaths per 1,000 live births.
071026
NV071021
Copyright © 2007 - The New Vision. All articles are republished on AEGIS by permission. Material may not be redistributed, posted to any other location, published or used for broadcast without written authorization from Managing Director/Editor-in-chief, The New Vision, P.O. Box 9815, Kampala - Uganda, Tel/fax: 256-41-235221, E-mail: wpike@newvision.co.ug.
AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Boehringer Ingelheim, Bridgestone/Firestone Charitable Trust, Bristol-Myers Squibb Company, Elton John AIDS Foundation, the National Library of Medicine, Roche and Trimeris, and donations from users like you. Always watch for outdated information. This article first appeared in 2007. This material is designed to support, not replace, the relationship that exists between you and your doctor.
AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.
Copyright ©1980, 2007. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .